202 related articles for article (PubMed ID: 2906529)
21. Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS.
Tsai GC; Stauch-Slusher B; Sim L; Hedreen JC; Rothstein JD; Kuncl R; Coyle JT
Brain Res; 1991 Aug; 556(1):151-6. PubMed ID: 1682006
[TBL] [Abstract][Full Text] [Related]
22. Alteration in extracellular amino acids after traumatic spinal cord injury.
Panter SS; Yum SW; Faden AI
Ann Neurol; 1990 Jan; 27(1):96-9. PubMed ID: 2301932
[TBL] [Abstract][Full Text] [Related]
23. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
24. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
25. [Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism].
Niebroj-Dobosz I; Janik P; Mickielewicz A; Jamrozik Z; Kwieciński H
Neurol Neurochir Pol; 2001; 35(1 Suppl):81-9. PubMed ID: 11732283
[TBL] [Abstract][Full Text] [Related]
26. Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.
Malessa S; Leigh PN; Bertel O; Sluga E; Hornykiewicz O
J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):984-8. PubMed ID: 1686899
[TBL] [Abstract][Full Text] [Related]
27. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.
Williams TL; Day NC; Ince PG; Kamboj RK; Shaw PJ
Ann Neurol; 1997 Aug; 42(2):200-7. PubMed ID: 9266730
[TBL] [Abstract][Full Text] [Related]
28. T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Panzara MA; Gussoni E; Begovich AB; Murray RS; Zang YQ; Appel SH; Steinman L; Zhang J
Neurobiol Dis; 1999 Oct; 6(5):392-405. PubMed ID: 10527806
[TBL] [Abstract][Full Text] [Related]
29. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors.
Whitehouse PJ; Wamsley JK; Zarbin MA; Price DL; Tourtellotte WW; Kuhar MJ
Ann Neurol; 1983 Jul; 14(1):8-16. PubMed ID: 6137185
[TBL] [Abstract][Full Text] [Related]
30. Trace element imbalances in amyotrophic lateral sclerosis.
Khare SS; Ehmann WD; Kasarskis EJ; Markesbery WR
Neurotoxicology; 1990; 11(3):521-32. PubMed ID: 2284056
[TBL] [Abstract][Full Text] [Related]
31. Excitotoxins and amyotrophic lateral sclerosis.
Munsat TL; Hollander D
Therapie; 1990; 45(3):277-9. PubMed ID: 2194313
[TBL] [Abstract][Full Text] [Related]
32. Alteration in amino acids in motor neurons of the spinal cord in amyotrophic lateral sclerosis.
Ono S; Imai T; Takahashi K; Jinnai K; Kanda F; Fukuoka Y; Hashimoto K; Shimizu N; Nagao K
J Neurol Sci; 1999 Aug; 167(2):121-6. PubMed ID: 10521551
[TBL] [Abstract][Full Text] [Related]
33. The wobbler mouse: amino acid contents in brain and spinal cord.
Krieger C; Perry TL; Hansen S; Mitsumoto H
Brain Res; 1991 Jun; 551(1-2):142-4. PubMed ID: 1913146
[TBL] [Abstract][Full Text] [Related]
34. Effect of inhibitors of gamma-glutamyl transpeptidase on the uptake of glutamate and aspartate into cultured astroglial cells from the glycogen body and cerebral hemispheres of the embryonic chick.
Jankásková B; Stastný F; Lisý V; Pearce B; Murphy S
Physiol Bohemoslov; 1988; 37(2):131-4. PubMed ID: 2905498
[TBL] [Abstract][Full Text] [Related]
35. Implications of altered brain ganglioside profiles in amyotrophic lateral sclerosis (ALS).
Rapport MM
Acta Neurobiol Exp (Wars); 1990; 50(4-5):505-13. PubMed ID: 2130665
[TBL] [Abstract][Full Text] [Related]
36. [Free amino acids in the spinal cord of a patient with amyotrophic lateral sclerosis].
Yoshino Y; Koike H; Akai K
Rinsho Shinkeigaku; 1976 Sep; 16(11-3ENA-NA-770111-770112):768-74. PubMed ID: 1034543
[No Abstract] [Full Text] [Related]
37. Brain glutamate deficiency in amyotrophic lateral sclerosis.
Perry TL; Hansen S; Jones K
Neurology; 1987 Dec; 37(12):1845-8. PubMed ID: 2891083
[TBL] [Abstract][Full Text] [Related]
38. Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis.
Ono S; Yamauchi M
Acta Neurol Scand; 1992 Nov; 86(5):481-4. PubMed ID: 1362315
[TBL] [Abstract][Full Text] [Related]
39. Distribution of the N-methyl-D-aspartate glutamate receptor subunit NR2A in control and amyotrophic lateral sclerosis spinal cord.
Samarasinghe S; Virgo L; de Belleroche J
Brain Res; 1996 Jul; 727(1-2):233-7. PubMed ID: 8842405
[TBL] [Abstract][Full Text] [Related]
40. Amino acids in autopsied human spinal cord. Selective changes in Friedreich's ataxia.
Butterworth RF; Giguère JF
Neurochem Pathol; 1984; 2(1):7-17. PubMed ID: 6536883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
